What Sent DaVita Stock Soaring On Tuesday?
Last year was a forgettable one for DaVita (NYSE: DVA) shareholders, but understandably so. The stock ended up losing 25% of its value in calendar 2025 due to a combination of a declining number of dialysis patients, subpar guidance for most of the year, uncertainty as to how much insurers were willing to continue reimbursing the company, and an embarrassing ransomware attack reported in April.
It's just possible, however, that the sellers overshot their target. As of 12:16 p.m. ET Tuesday, DaVita stock is up an impressive 20.3% in response to fourth-quarter results and full-year guidance that show more promise than problems.
For the three-month stretch ending in December, DaVita turned $3.62 billion in revenue into an adjusted per-share profit $3.40. That's well up from the year-earlier comparison of $2.51 per share, when the company reported revenue of just under $3.3 billion. Perhaps more important, though, both of these numbers also topped analysts' expectations.
Source Fool.com
